Search

Search Constraints

You searched for: Author/Creator Vitale, Maria Grazia

Search Results

3. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

4. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

5. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

6. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. (August 2018)

7. Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index. (January 2021)

9. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. Issue 11 (30th September 2020)

10. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. Issue 11 (November 2020)